<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Lyons Herring | Activity</title>
	<link>https://www.catswannabecats.com/members/editorisland8/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/editorisland8/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lyons Herring.</description>
	<lastBuildDate>Wed, 24 Jun 2026 15:14:21 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">879eb2e6f69f0a5cfada9a0b85cd6a7a</guid>
				<title>Lyons Herring posted an update: AIMS CircRNAs are emerging as a novel class of non-coding [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/25446/</link>
				<pubDate>Mon, 09 Jun 2025 07:04:42 -0400</pubDate>

									<content:encoded><![CDATA[<p>AIMS CircRNAs are emerging as a novel class of non-coding RNAs that play crucial roles in malignant cancer. However, the expression profile and potential mechanism of circRNAs in gliomas remain uncharacterized. In this study, we aim to investigate abnormally expressed circRNAs during glioma pathogenesis and find out potential therapeutic targets&hellip;<span class="activity-read-more" id="activity-read-more-25446"><a href="https://www.catswannabecats.com/activity/p/25446/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5415efb2f27b2a74b6501e5a32db51ef</guid>
				<title>Lyons Herring posted an update: Although there was some variation at the transposon level [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/14732/</link>
				<pubDate>Mon, 02 Jun 2025 07:03:52 -0400</pubDate>

									<content:encoded><![CDATA[<p>Although there was some variation at the transposon level (mostly Tn4401a, 584/604 (97%) isolates; predominantly with ATTGA-ATTGA target site duplications, 465/604 77% isolates), bla KPC spread appears to have been supported by highly fluid, modular exchange of larger genetic segments amongst plasmid populations dominated by IncFIB (580/604&hellip;<span class="activity-read-more" id="activity-read-more-14732"><a href="https://www.catswannabecats.com/activity/p/14732/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7d3e05cca322eeefdf514771afe7e9fe</guid>
				<title>Lyons Herring posted an update: CLBP_L (p &#60; 0,001) and increased brain response in the fro [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/11613/</link>
				<pubDate>Sun, 01 Jun 2025 07:07:49 -0400</pubDate>

									<content:encoded><![CDATA[<p>CLBP_L (p &lt; 0,001) and increased brain response in the frontal pole and paracingulate region in control vs. CLBP_L (p &lt; 0.001) during acute pain stimulation.</p>
<p> The modulation of acute pain participates in the mechanism propagating chronic pain perception. The lower activation in the superior frontal gyrus observed in the CLBP_L group compare&hellip;<span class="activity-read-more" id="activity-read-more-11613"><a href="https://www.catswannabecats.com/activity/p/11613/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e542b556cfec196b47affb126625c723</guid>
				<title>Lyons Herring posted an update: The number and type of therapeutic options available to [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/6207/</link>
				<pubDate>Sat, 31 May 2025 16:02:20 -0400</pubDate>

									<content:encoded><![CDATA[<p>The number and type of therapeutic options available to treat patients with multiple myeloma has risen dramatically over recent years, offering exciting opportunities to significantly improve the future management of this currently incurable disease. Some of the latest advances in the settings of newly diagnosed and relapsed/refractory multiple&hellip;<span class="activity-read-more" id="activity-read-more-6207"><a href="https://www.catswannabecats.com/activity/p/6207/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9c3aec87c2ead65adf6cba7939839c12</guid>
				<title>Lyons Herring became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/6120/</link>
				<pubDate>Sat, 31 May 2025 15:52:17 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>